Sumita Ray, J.D.
Ms. Ray has been in the biotech industry for over 25 years and has held positions as Chief Legal & Compliance Officer for over a decade at various publicly traded companies. Most recently, she served as Chief Legal, Compliance & Administrative Officer and Corporate Secretary at Vaxxinity (Nasdaq: VAXX), a formerly public biotechnology company. Prior to that, Ms. Ray held the position of Chief Legal, Compliance & Administrative Officer and Corporate Secretary at the public biotechnology companies of Instil Bio, Inc. (Nasdaq: TIL), and Calithera BioSciences, Inc. (Nasdaq: CALA). Prior to that, Ms. Ray held senior and executive leadership roles of increasing responsibility at Astrazeneca, Genentech, Elan Pharmaceuticals and Pharmacyclics. Ms. Ray began her career in private practice as a pharmaceutical and products liability litigator at the law firm of Montgomery, McCracken, Walker & Rhoads LLP. Ms. Ray currently serves on the Board of Directors of Biomea Fusion, Inc. (Nasdaq: BMEA) to which she was appointed in July 2021. She holds a Juris Doctor from Temple University School of Law and a B.S. in Microbiology with a minor in Chemistry from the University of Arizona. She is admitted to practice in Pennsylvania and New Jersey.
« Go Back